You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 93 No. 6, June 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  THERAPY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Action of Methotrexate on Skin and Intestinal Epithelium in Psoriasis

LIONEL FRY, MD, MRCP; R. M. H. McMINN, MD, PhD

Arch Dermatol. 1966;93(6):726-730.


Abstract

Twelve patients with psoriasis have been treated with parenteral methotrexate at weekly intervals. Ten patients showed varying degrees of clinical improvement within six weeks, but two did not respond. In some cases, there was a dramatic fall in the mitotic activity of psoriatic epidermis at three and 24 hours after methotrexate, but the count rose again by the third day although in the patients who improved clinically the mitotic index did not return to the pretreatment level by seven days. In other cases there was a gradual fall in the mitotic count from the first to the seventh day. There was a marked fall in the mitotic index of the small intestinal epithelium after methotrexate, but unlike the psoriatic epidermis the mitotic count returned to the preinjection level by the seventh day. The results support the theory that the "healing" action of methotrexate in psoriasis is primarily a direct one on the premitotic and mitotic cells of the epidermis.



Author Affiliations

LONDON

From the Department of Dermatology, London Hospital (Dr. Fry) and the Department of Anatomy, King's College, University of London (Dr. McMinn).


Footnotes

Accepted for publication March 11, 1966.

Reprint requests to Department of Dermatology, London Hospital, Whitechapel, London E 1, England (Dr. Fry).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cirrhosis Caused by Methotrexate in the Treatment of Psoriasis
Muller et al.
Arch Dermatol 1969;100:523-530.
ABSTRACT  

Site of Action of Methotrexate in Psoriasis
Comaish and Juhlin
Arch Dermatol 1969;100:99-105.
ABSTRACT  

Topical Methotrexate in Psoriasis
Fry and McMinn
Arch Dermatol 1967;96:483-488.
ABSTRACT  

Methotrexate: Effects on the Enzymes of Carbohydrate Metabolism in Psoriasis
Halprin and Ohkawara
Arch Dermatol 1967;96:565-571.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.